[{"address1": "101 Lindenwood Drive", "address2": "Suite 225", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "(484) 875-3192", "website": "https://www.annovisbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Malvern, Pennsylvania.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maria L. Maccecchini Ph.D.", "age": 72, "title": "Founder, CEO, President, Interim Principal Financial Officer & Executive Director", "yearBorn": 1951, "fiscalYear": 2023, "totalPay": 681200, "exercisedValue": 0, "unexercisedValue": 5637696}, {"maxAge": 1, "name": "Mr. Mark K. White", "age": 67, "title": "Chief Business Officer & Director", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheng  Fang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eve M. Damiano M.S., RAC", "title": "Senior Vice President of Regulatory Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Gaines", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Blake  Jensen", "title": "Head of Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hilda  Maibach", "title": "Senior Vice President of Statistics", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.61, "open": 8.59, "dayLow": 8.0, "dayHigh": 8.7, "regularMarketPreviousClose": 8.61, "regularMarketOpen": 8.59, "regularMarketDayLow": 8.0, "regularMarketDayHigh": 8.7, "forwardPE": -4.5082874, "volume": 269811, "regularMarketVolume": 269811, "averageVolume": 234854, "averageVolume10days": 205310, "averageDailyVolume10Day": 205310, "bidSize": 800, "askSize": 800, "marketCap": 106520640, "fiftyTwoWeekLow": 4.53, "fiftyTwoWeekHigh": 22.49, "fiftyDayAverage": 8.5266, "twoHundredDayAverage": 9.04155, "currency": "USD", "enterpriseValue": 99948864, "floatShares": 10822005, "sharesOutstanding": 13054000, "sharesShort": 1358798, "sharesShortPriorMonth": 1196148, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.1041, "heldPercentInsiders": 0.21564, "heldPercentInstitutions": 0.08071999, "shortRatio": 5.96, "shortPercentOfFloat": 0.13270001, "impliedSharesOutstanding": 13054000, "bookValue": 0.532, "priceToBook": 15.338346, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -40939112, "trailingEps": -4.54, "forwardEps": -1.81, "52WeekChange": 0.36227047, "SandP52WeekChange": 0.35905516, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "ANVS", "underlyingSymbol": "ANVS", "shortName": "Annovis Bio, Inc.", "longName": "Annovis Bio, Inc.", "firstTradeDateEpochUtc": 1580308200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "e153bc75-9830-375d-bf5e-330db4df878a", "messageBoardId": "finmb_622711087", "gmtOffSetMilliseconds": -18000000, "currentPrice": 8.16, "targetHighPrice": 72.0, "targetLowPrice": 21.0, "targetMeanPrice": 34.8, "targetMedianPrice": 26.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 12636630, "totalCashPerShare": 0.916, "quickRatio": 2.344, "currentRatio": 2.664, "returnOnAssets": -1.5458, "returnOnEquity": -5.9669704, "freeCashflow": -11572214, "operatingCashflow": -22974234, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-11"}]